Independent Market Access and Reimbursement Risk Assessment.

Built by former payers, HTA reviewers, and Industry Experts. 

Market access risk by therapeutic area

MARA assesses reimbursement risk one drug and one indication at a time, and publishes each assessment with its "as of" date. This page is the map of that record: every therapeutic area MARA covers, in one place. The largest areas have a page of their own — a short account of what payers ask in that field, then the dated assessments. The remaining areas are listed here in full, grouped by area and newest first, until their own pages follow. When a drug has been re-assessed, the earlier version stays on the record beneath the current one, marked as replaced — never removed, never silently changed. Assessments are produced on MARA's own initiative for awareness; the current MARA Rating for any drug is available on request.

Areas with their own page

Gynecology — 4 dated assessments

Urology — 1 dated assessment

For how a MARA Rating is built, see the methodology and what a MARA Rating is. To request the current rating for any drug in any area, use the contact form.